Organization
Wozniak Industries, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Wozniak Industries, Inc.

... announced that Dalton Pharma Services (Dalton) has completed the good manufacturing practice (GMP) glass vial filling stage for Metablok, the Company's lead drug candidate for ...
... announced that the companies have entered into an exclusive partnership for the GMP manufacturing of certain of Inhibrx's protein-based therapeutics. The agreement showcases the expansive ...
... retail consumer insights, analytics, and consulting for the Natural, Organic, and Specialty Products Industries, announces record growth in personnel over the past year. In March ...
... has engaged Dalton Pharma Services (Dalton) to perform the good manufacturing practice (GMP) campaign for Metablok, (LSALT peptide), the Company's drug candidate for preventing acute ...
... for net proceeds of $1,250,000. February 27: Arch Biopartners Announces Start of GMP Manufacturing for Metablok at CSBio The first target indication for Metablok is ...
... for the manufacturing at the Centre of Excellence in Cellular Therapy (CETC) GMP manufacturing facility. It is critical for us to have a supplier with ...
... retail consumer insights, analytics, and consulting for the Natural, Organic, and Specialty Products Industries, announces Chris Locke as Chief Financial Officer. Locke will lead all ...
... for net proceeds of $1,250,000. February 27: Arch Biopartners Announces Start of GMP Manufacturing for Metablok at CSBio The first target indication for Metablok is ...
... for net proceeds of $1,250,000. February 27: Arch Biopartners Announces Start of GMP Manufacturing for Metablok at CSBio The first target indication for Metablok is ...
... for net proceeds of $1,250,000. February 27: Arch Biopartners Announces Start of GMP Manufacturing for Metablok at CSBio The first target indication for Metablok is ...
Subscribe now for full coverage on Wozniak Industries, Inc.
Start My Free Trial